![[Next-Generation Sequencing Book]](https://www.bioinformatics.org/images/ack_banners/NGS-Book-1-728x90.png)
-
RESPONSIBILITIES
In this M&S role, this individual will develop mechanistic drug effect and disease progression models (in particular for HCV, T2DM, and Alzheimer’s disease) to facilitate drug development decisions, and will be responsible for: (1) collaborating with cross-functional team members to address key program and portfolio level questions by disease progression models; (2) resourcing and execution of the M&S plans; (3) reporting and interpretation of M&S results to inform decisions at clinical development milestones, and (4) contributing to regulatory submissions (pre- and post-approval). The individual will also be expected to develop M&S plans to bridge available data from compounds within and across development programs to inform portfolio level decisions. This individual will represent the M&S function in cross-functional matrix/project teams, and identify and respond to opportunities for M&S input over the course of drug development.REQUIREMENTS
- Ph.D. and/or M.D. in medical/pharmaceutical sciences or engineering or a related field
- 5+ years of experience in M&S (population pharmacokinetic and exposure-response) analyses using S-PLUS/R and NONMEM
- Advanced expertise in developing mechanistic drug effect and disease progression models
- Strong oral and written communication skills necessary to formally present and report information internally and externally is required.
- The ability to work in a dynamic team oriented environment is essential.
HOW TO APPLY
To apply for this position please copy and paste the following URL into your browser: http://ars2.equest.com/?response_id=ac91b466a125aa5bdb4f2dfdf3f80b66
![[Photo]](https://www.bioinformatics.org/images/photo.php?photo_id=39548)
Discussion forums: Opportunity: Director (#0902206) @ Bristol-Myers Squibb--Princeton, NJ (US)
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be logged in to post a reply.